Overview

Continuous Temozolomide in Patients With Advanced or Metastatic Soft Tissue Sarcoma or Metastatic Breast Cancer

Status:
Completed
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether treatment with temozolomide can effect the survival of patients with advanced breast cancer or soft tissue sarcoma.
Phase:
Phase 2
Details
Lead Sponsor:
University of Washington
Collaborator:
Schering-Plough
Treatments:
Dacarbazine
Temozolomide